5-methoxypsoralen has been researched along with Inflammation in 9 studies
5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Analog 19 was a more potent anti-inflammatory agent than the reference compound indomethacin and of comparable cytocompatibility to 8-MOP whereas analog 24 was a weaker inhibitor of inflammation than indomethacin and significantly more cytotoxic than 8-MOP." | 3.79 | Syntheses and evaluation of the antioxidant activity of novel methoxypsoralen derivatives. ( Athanassopoulos, CM; Avgoustakis, K; Bariamis, SE; Hadjipavlou-Litina, D; Kontogiorgis, C; Marin, M; Papaioannou, D; Romeo, G; Sindona, G; Tsimali, Z, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Bariamis, SE | 1 |
| Marin, M | 1 |
| Athanassopoulos, CM | 1 |
| Kontogiorgis, C | 1 |
| Tsimali, Z | 1 |
| Papaioannou, D | 1 |
| Sindona, G | 1 |
| Romeo, G | 1 |
| Avgoustakis, K | 1 |
| Hadjipavlou-Litina, D | 1 |
| Luo, T | 1 |
| Jia, X | 1 |
| Feng, WD | 1 |
| Wang, JY | 1 |
| Xie, F | 1 |
| Kong, LD | 1 |
| Wang, XJ | 1 |
| Lian, R | 1 |
| Liu, X | 1 |
| Chu, YJ | 1 |
| Wang, Y | 2 |
| Xu, AL | 1 |
| Jiang, Y | 1 |
| Nguyen, TV | 1 |
| Jin, J | 1 |
| Yu, ZN | 1 |
| Song, CH | 1 |
| Chai, OH | 1 |
| Yang, Y | 1 |
| Zheng, K | 1 |
| Mei, W | 1 |
| Yu, C | 1 |
| Yu, B | 1 |
| Deng, S | 1 |
| Hu, J | 1 |
| Singh, G | 2 |
| Kaur, A | 1 |
| Kaur, J | 1 |
| Bhatti, MS | 1 |
| Singh, P | 2 |
| Bhatti, R | 2 |
| He, Y | 1 |
| Zisan, Z | 1 |
| Lu, Z | 1 |
| Zheng, L | 1 |
| Zhao, J | 1 |
| Singh, A | 1 |
| Muret, P | 1 |
| Makki, S | 1 |
| Urien, S | 1 |
| Agache, P | 1 |
| Bechtel, P | 1 |
| Tillement, JP | 1 |
9 other studies available for 5-methoxypsoralen and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Syntheses and evaluation of the antioxidant activity of novel methoxypsoralen derivatives.
Topics: Anti-Inflammatory Agents; Antioxidants; Dose-Response Relationship, Drug; Furocoumarins; Glycine max | 2013 |
Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagy.
Topics: 5-Methoxypsoralen; Animals; Caspase 1; Inflammasomes; Inflammation; Interleukin-1beta; Mice; Mitopha | 2023 |
Bergapten ameliorates combined allergic rhinitis and asthma syndrome after PM2.5 exposure by balancing Treg/Th17 expression and suppressing STAT3 and MAPK activation in a mouse model.
Topics: 5-Methoxypsoralen; Animals; Asthma; Cytokines; Disease Models, Animal; Inflammation; Mice; Mice, Inb | 2023 |
Anti-inflammatory and proresolution activities of bergapten isolated from the roots of Ficus hirta in an in vivo zebrafish model.
Topics: 5-Methoxypsoralen; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Female; Ficus; Inflamm | 2018 |
Bergapten inhibits chemically induced nociceptive behavior and inflammation in mice by decreasing the expression of spinal PARP, iNOS, COX-2 and inflammatory cytokines.
Topics: 5-Methoxypsoralen; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Cyt | 2019 |
Bergapten alleviates osteoarthritis by regulating the ANP32A/ATM signaling pathway.
Topics: 5-Methoxypsoralen; Animals; Anti-Inflammatory Agents; Ataxia Telangiectasia Mutated Proteins; Cell P | 2019 |
Bergapten Ameliorates Vincristine-Induced Peripheral Neuropathy by Inhibition of Inflammatory Cytokines and NFκB Signaling.
Topics: 5-Methoxypsoralen; Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cytokines; | 2019 |
Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
Topics: 5-Methoxypsoralen; Blood Proteins; Erythrocytes; Extracellular Space; Fatty Acids; gamma-Globulins; | 1993 |